Side By Side Later Stage EIS Fund
Apply online only
Please apply online and send funds by bank transfer. We accept and process online applications until the advertised deadline for each investment.
The SBS Later Stage fund looks to invest in EIS qualifying companies that already have a developed customer base and revenue.
- Target return 3.7x (net of fees and excluding tax relief – returns not guaranteed)
- Expected exit timeline of 8 years (not guaranteed)
- Target of up to 8 portfolio companies (not guaranteed) with a minimum of three
- Subscription should be deployed within 12 months (not guaranteed)
- Minimum investment £25,000 - you can apply online
Read important documents and apply
Although The SideBySide Partnership (SBS) is new to the EIS market, its managing director, John Bailye, has experience in investing and developing early-stage companies. He gained his initial business experience as the founder and CEO of Dendrite International Inc., which floated in 1996 and was sold in 2007 for $700 million. He subsequently helped set up the New Jersey Technology Council which now has approximately 1,500 entrepreneur members, and has made a number of angel investments.
Members of The SideBySide Partnership will potentially look to co-invest in up to 10% of the fund.
Watch a video interview with John Bailye:
The fund will look to take a hands-on approach with its portfolio. By providing active support and mentoring, SBS hopes to guide management teams around common pitfalls. SBS will help investee companies produce a detailed one-year business plan and then spend at least two days a month mentoring each management team.
SBS plans to evaluate approximately 600 opportunities annually. However, in order to enable the team to provide close support to the investee companies, the fund expects to hold a maximum of eight portfolio companies at any point. Therefore, after the initial portfolio has been put together, it will only invest in a new company once an exit has been achieved.
The fund will focus on businesses whose products or services have enhanced an existing market or created a new one through the application of technology. It will invest across a range of sectors such as FinTech, MedTech and SportTech. The average investment is expected to be up to £200,000, however, the fund may make smaller investments of £50,000 - £100,000 into earlier stage companies if the investment team believes there is sufficient potential.
Risks – important
This, like all investments available through Wealth Club, is only for experienced investors happy to make their own investment decisions without advice.
This is the first iteration of this fund and the SBS Partnership are new to investing within an EIS framework.
EIS investments are high-risk so should only form part of a balanced portfolio and you should not invest money you cannot afford to lose. They also tend to be illiquid and hard to sell and value. Before you invest, please carefully read the Risks and Commitments and the offer documents to ensure you fully understand the risks.
Tax rules can change and benefits depend on circumstances.
This fund invests in early-stage businesses which are more likely to fail than larger ones, so you should expect a number of failures in the portfolio.
A summary of the main charges and savings is shown below. Some of these will be payable by the investor, whilst others by the investee companies. The investment may have additional charges and expenses: please see the provider documents, including the Key Information Document, for more details.
|Full initial charge||0%|
|Wealth Club initial saving||—|
|Net initial charge through Wealth Club||0%||Annual management charge||0%|
|Performance fee||20%*||Investee company charges|
More detail on the charges
Read important documents and apply
Wealth Club aims to make it easier for experienced investors to find information on – and apply for – tax-efficient investments. You should base your investment decision on the provider's documents and ensure you have read and fully understand them before investing. This review is a marketing communication. It is not advice or a personal or research recommendation to buy the investment mentioned. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.
- Target return
- Funds raised / sought
- Minimum investment